Chieko Mitaka Selected Research

Chieko Mitaka Research Topics

Disease

11	Septic Shock (Toxic Shock Syndrome) 01/2022 - 04/2003
8	Sepsis (Septicemia) 01/2022 - 04/2003
5	Acidosis 04/2022 - 05/2005
5	Pulmonary Edema 04/2022 - 07/2002
4	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 08/2003
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 07/2014 - 04/2003
4	Hypoxia (Hypoxemia) 11/2013 - 07/2002
4	Ischemia 12/2008 - 01/2004
3	Inflammation (Inflammations) 12/2014 - 11/2013
3	Lung Injury 05/2010 - 07/2002
2	Multiple Organ Failure (MODS) 05/2021 - 04/2003
2	Infections 01/2015 - 07/2014
2	Pneumonia (Pneumonitis) 11/2013 - 05/2010
1	Pulmonary Alveolar Proteinosis 04/2022
1	Lung Neoplasms (Lung Cancer) 04/2022
1	Blister (Bulla) 10/2021
1	Endotoxemia 05/2021
1	Disseminated Intravascular Coagulation 01/2021
1	Neoplasms (Cancer) 09/2020
1	Critical Illness (Critically Ill) 01/2020
1	Pneumococcal Pneumonia 10/2018
1	Aspiration Pneumonia 10/2018
1	Esophageal Neoplasms (Esophageal Cancer) 10/2018
1	Vascular Diseases (Vascular Disease) 10/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2017
1	Reperfusion Injury 12/2014
1	Wounds and Injuries (Trauma) 12/2014
1	Noncommunicable Diseases 07/2014
1	Hypotension (Low Blood Pressure) 11/2013
1	Cardiac Arrhythmias (Arrythmia) 01/2011
1	Hyperventilation 05/2010
1	Abdominal Aortic Aneurysm 03/2008
1	Shock 05/2005
1	Bacterial Infections (Bacterial Infection) 01/2005
1	Gram-Negative Bacterial Infections 01/2005
1	Virus Diseases (Viral Diseases) 01/2005
1	Aortic Aneurysm (Aneurysm, Aortic) 08/2003
1	Renal Insufficiency (Renal Failure) 08/2003
1	Pulmonary Hypertension 07/2002

Drug/Important Bio-Agent (IBA)

9	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022 - 11/2009
8	EndotoxinsIBA 05/2021 - 01/2005
7	Atrial Natriuretic Factor (ANF)IBA 01/2017 - 07/2002
6	CytokinesIBA 05/2021 - 01/2004
6	Messenger RNA (mRNA)IBA 12/2014 - 01/2004
5	CreatinineIBA 01/2017 - 01/2011
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2015 - 11/2013
3	C-Reactive ProteinIBA 01/2020 - 01/2005
3	ProcalcitoninIBA 07/2014 - 01/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021 - 04/2003
2	PotassiumIBA 12/2014 - 11/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 01/2007
2	ADAM17 ProteinIBA 12/2008 - 01/2007
1	Saline SolutionIBA 04/2022
1	Propofol (Diprivan)FDA LinkGeneric 04/2022
1	Desflurane (I 653)FDA Link 04/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2021
1	ThrombomodulinIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Lipocalin-2IBA 01/2020
1	CollagenIBA 10/2017
1	Natriuretic AgentsIBA 12/2014
1	Interleukin-6 (Interleukin 6)IBA 12/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2013
1	3-aminobenzamideIBA 11/2013
1	LipopolysaccharidesIBA 11/2013
1	SaltsIBA 05/2010
1	SolutionsIBA 05/2010
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2010
1	BuffersIBA 12/2008
1	Superoxide DismutaseIBA 12/2008
1	acetovanillone (apocynin)IBA 12/2008
1	Krebs-Henseleit solutionIBA 12/2008
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	Oxygen (Dioxygen)IBA 05/2005
1	NF-kappa B (NF-kB)IBA 05/2005
1	Pyrrolidinones (Pyrrolidones)IBA 05/2005
1	Indicators and Reagents (Reagents)IBA 01/2005
1	NeopterinIBA 01/2005
1	Endothelins (Endothelin)IBA 09/2004
1	NitratesIBA 04/2003
1	NitritesIBA 04/2003
1	Furosemide (Lasix)FDA LinkGeneric 07/2002
1	Oleic Acid (Oleate)IBA 07/2002

Therapy/Procedure

9	Hemoperfusion 01/2022 - 11/2009
4	Therapeutics 04/2022 - 11/2009
3	Artificial Respiration (Mechanical Ventilation) 04/2022 - 12/2014
2	General Anesthesia 04/2022 - 10/2021
2	One-Lung Ventilation 10/2021 - 09/2020
2	Airway Management 10/2021 - 09/2020
2	Esophagectomy 01/2020 - 10/2018
1	Anesthesia 04/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2021
1	Tracheostomy 10/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2011
1	Continuous Positive Airway Pressure 05/2010
1	Transplantation 01/2006
1	Controlled Hypotension 05/2005